There was no statistically significant difference between the expression level of circRNAs, hsa_circ_0001785 (Circ‐ELP3) or hsa_circ_100219 (Circ‐FAF1), in pre‐treatment status with patients' age, breast cancer clinical stage and grade, and the affected breast side (Tables 2 and 3). This evidence concerns the gene ELP3 and breast cancer.